Skip to Content

L217 (Lamotrigine (Chewable Dispersible) 5 mg)

Pill with imprint L217 is White, Capsule-shape and has been identified as Lamotrigine (Chewable Dispersible) 5 mg. It is supplied by Alembic Pharmaceuticals Limited.

Lamotrigine is used in the treatment of bipolar disorder; schizoaffective disorder; seizure prevention; epilepsy and belongs to the drug class triazine anticonvulsants. Risk cannot be ruled out during pregnancy. Lamotrigine 5 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for L217

Lamotrigine (Chewable Dispersible)

Imprint
L217
Strength
5 mg
Color
White
Size
8.00 mm
Shape
Capsule-shape
Availability
Prescription only
Drug Class
Triazine anticonvulsants
Pregnancy Category
C - Risk cannot be ruled out
CSA Schedule
Not a controlled drug
Labeler / Supplier
Alembic Pharmaceuticals Limited
National Drug Code (NDC)
46708-0095
Inactive Ingredients
mannitol, crospovidone, povidone k30, microcrystalline cellulose, aspartame, silicon dioxide, magnesium stearate, magnesium silicate, blackberry

Note: Inactive ingredients may vary.

Get help with Imprint Code FAQs.

Related Images for "L217"

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.